Benzinga's Volume Movers

surged 5.56% to $43.69. The volume of Advent Software shares traded 4246% higher than normal. SS&C Technologies Holdings announced its plans to acquire Advent Software for $2.7 billion in cash.

shares climbed 10.52% to $49.50. The volume of Esperion Therapeutics shares traded was 943% higher than normal. Esperion Therapeutics announced the removal of PPAR partial clinical hold for ETC-1002.

shares rose 6.03% to $11.79. The volume of Radcom shares traded was 596% higher than normal. Radcom reported Q4 adjusted earnings of $0.20 per share on revenue of $7.2 million.

shares moved up 9.26% to $59.60. The volume of SS&C Technologies traded was 404% higher than normal. SS&C Technologies announced its plans to acquire Advent Software for $2.7 billion in cash.